
The Potential Rise in the Price of Vertex Pharmaceuticals, Inc (VRTX) following insiders activity
Vertex Pharmaceuticals, Inc’s recently made public that its Officer ALTSHULER DAVID acquired Company’s shares for reported $1.58 million on Mar
Vertex Pharmaceuticals, Inc’s recently made public that its Officer ALTSHULER DAVID acquired Company’s shares for reported $1.58 million on Mar
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Vertex Pharmaceuticals, Inc’s filing revealed that its EVP, Chief Scientific Officer ALTSHULER DAVID unloaded Company’s shares for reported $0.53 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Vertex Pharmaceuticals, Inc revealed its Officer Tatsis Ourania acquired Company’s shares for reported $0.11 million on Feb
Vertex Pharmaceuticals, Inc’s filing revealed that its Officer Biller Jonathan acquired Company’s shares for reported $1.58 million on Feb 11
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Vertex Pharmaceuticals,
In a filing, Vertex Pharmaceuticals, Inc revealed its EVP, Chief Scientific Officer ALTSHULER DAVID unloaded Company’s shares for reported $7178.0
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.